"Choose us for your clinical research needs, whether you're a sponsor or a potential patient. Contact our facility in the Dallas, TX, area to learn how to get involved."

During the past decade, InSite Clinical Research conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 28 clinical trials were completed, i.e. on average, 71.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "InSite Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "Indivior Inc." with 5 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "InSite Clinical Research" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "InSite Clinical Research" are "Schizophrenia" (20 trials), "Major Depressive Disorder" (4 trials), "Attention Deficit Hyperactivity Disorder" (3 trials), "Bipolar I Disorder" (3 trials) and "Depressive Disorder, Major" (3 trials). Many other conditions were trialed in "InSite Clinical Research" in a lesser frequency.

Most popular intervention types in "InSite Clinical Research" are "Drug" (68 trials), "Other" (6 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Xanomeline and Trospium Chloride Capsules" (4 trials), "RBP-6000" (3 trials), "placebo" (3 trials) and "Brexpiprazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "InSite Clinical Research" are 69 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "InSite Clinical Research". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in InSite Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in InSite Clinical Research, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 1 trials that are defined as “Not Applicable".